CF negotiations will continue next week

Vertex’s Jeffrey Leiden and U.K. Health Secretary Matthew Hancock have agreed to meet again next week to continue discussions on the availability of the biotech's cystic fibrosis drugs in the U.K.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) said in a statement Monday that Leiden, the company’s chairman, president and CEO, had a "constructive discussion" with Hancock on the first day of negotiations...